SCM
QTTB icon

Springhouse Capital Management’s Q32 Bio QTTB Stock Holding History

Springhouse Capital Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,222
Closed -$50.4K – 32
2022
Q4 		$50.4K Buy
+2,222
New +$59K 0.07% 32

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Springhouse Capital Management's QTTB Position: Q1 2023 in Review

Springhouse Capital Management sold out of Q32 Bio (QTTB) in Q1 2023, closing a stake of 2,222 shares — an estimated $50.4K sold.

Springhouse Capital Management first reported a position in QTTB in Q4 2022 and held it in 1 quarter. The position peaked at $50.4K in Q4 2022. 62 funds tracked by Wall St. Rank hold QTTB as of Q1 2023.

  • Springhouse Capital Management reported no remaining Q32 Bio position as of Q1 2023 after selling out during the quarter.
  • Springhouse Capital Management sold 2,222 Q32 Bio shares in Q1 2023, an estimated $50.4K.
  • Springhouse Capital Management first reported a position in Q32 Bio in Q4 2022 and held it in 1 quarter.
  • Springhouse Capital Management's Q32 Bio position peaked at $50.4K in Q4 2022.
  • 62 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2023.

Based on Springhouse Capital Management's 13F filing for Q1 2023, filed 15 May 2023.